Crossject engage Syn
Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-Unis
January 04, 2024 12:00 ET | CROSSJECT
Communiqué de presse Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-Unis  Crossject élargit ses activités d'accès au marché dans le cadre des...
Crossject engages Sy
Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®
January 04, 2024 12:00 ET | CROSSJECT
Press Release Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®  Crossject expanding market access activities in preparation for filing for marketing authorization ...
Crossject signe un a
Crossject signe un accord de commercialisation pour ZEPIZURE® en Europe du Nord
December 22, 2023 01:30 ET | CROSSJECT
Crossject recevra jusqu'à 1 million d'euros en vue des approbations de mise sur le marché, plus un multiple des coûts de production lié à la marge brute L'accord, signé avec un partenaire stratégique...
Crossject signs ZEPI
Crossject signs ZEPIZURE® commercialization agreement for northern Europe
December 22, 2023 01:30 ET | CROSSJECT
Crossject to receive up to €1 million on marketing approvals, plus a markup on sales linked to gross margin Agreement, with undisclosed strategic partner, allows Crossject to benefit from strong...
Logo.png
Positive Results Drive Foresight Into Commercialization Agreement with Leading Global Defense Company Elbit Systems Securing up to $4 Million in Revenue
December 18, 2023 08:15 ET | Foresight Autonomous Holdings Ltd.
Ness Ziona, Israel, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, achieved a...
Cingulate_Logo_400x400_twitter.jpg
Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301
March 13, 2023 06:45 ET | Cingulate Inc.
Go-to-Market Solution Provides Full Commercial Support for the First, True Entire Active-Day Medication Designed to treat ADHD Indegene Model Geared for Efficient National Commercial Launch in...
SINTX & O2TODAY Sign Commercialization Agreement
O2TODAY and SINTX Technologies Enter Commercialization Agreement to Fight COVID-19
February 25, 2021 09:00 ET | SINTX Technologies, Inc.
SALT LAKE CITY, UT, Feb. 25, 2021 (GLOBE NEWSWIRE) -- O2TODAY ("O2TODAY"), a mask company that develops, manufactures and commercializes face masks for medical and non-medical uses, and SINTX...